Inova Health Care Services
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Inova Health Care Services sits in the top decile of US sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count).
Inova Health Care Services: 75 sponsored US clinical trials, 22 recruiting.
Inova Health Care Services sponsors 75 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 32 completed. 10 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 3 trials.
Top-decile sponsor footprint
Inova Health Care Services ranks in the top decile of sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
32 of 48 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
75 total, page 2 of 2
Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention
NCT03048019
Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease
NCT03247972
The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
NCT03040622
Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture
NCT03040661
Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques
NCT02845245
Vitamin D Supplementation in Women With DCIS and/or LCIS
NCT02936999
Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients
NCT02751151
Vorapaxar on Thrombin Generation and Coagulability
NCT03207451
Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
NCT02178566
Del Nido Cardioplegia Randomized Trial
NCT02442050
Pain Management in Response to Exparel vs. Standard Bupivicaine
NCT02499159
Efficacy of Animal Assisted Therapy in the Treatment of Patients With Traumatic Brain Injury
NCT05217030
Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
NCT02017249
Comparison of Insulin Therapy in Treating Post-Transplant Diabetes
NCT01963728
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
NCT01808456
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
NCT01835080
Continuous Subpleural Infusion of Bupivacaine
NCT01566838
CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM
NCT01535807
fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults
NCT01320748
Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation
NCT01416935
The Six Minute Walk Test: Influence of Instruction on Results
NCT01789996
Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery
NCT01033916
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
NCT01023477
New Individualized Therapy Trial for Metastatic Colorectal Cancer
NCT00867334
Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
NCT01028105
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 10 |
| Phase 3 | 1 |
| Phase 4 | 9 |
What is open in the Inova Health Care Services pipeline
22 recruiting of 75 indexed (29% open); 32 completed (43%).
Phase mix: 10 late (III/IV) vs 15 early (I/II) (balanced across stages).
Top condition: Heart Failure (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Inova Health Care Services: open-pipeline peers nationwide
Peers matched on 75 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Inova Health Care Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 75 trials (± recruiting share)
- C. R. Bard · 75 trials · 5% recruiting
- ECOG-ACRIN Cancer Research Group · 75 trials · 16% recruiting
- Hartford Hospital · 75 trials · 11% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Children's Hospital Los Angeles · 29% recruiting · 119 trials
- Natural Immune Systems · 29% recruiting · 17 trials
- Ono Pharmaceutical Co. · 29% recruiting · 17 trials
- Queen's Medical Center · 29% recruiting · 17 trials
Related
What to do with this Inova Health Care Services page
75 registered trials is a research-attention snapshot, not an endorsement of Inova Health Care Services or any single study.
- 22 of Inova Health Care Services's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Inova Health Care Services studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Inova Health Care Services pipeline card: 75 registered trials from official public datasets.Report a data error.